home All News open_in_new Full Article

Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment.


today 34 h. ago attach_file Politics

attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics


ID: 90096550
Add Watch Country

arrow_drop_down